Your browser doesn't support javascript.
loading
Disposition of perphenazine is related to polymorphic debrisoquin hydroxylation in human beings.
Dahl-Puustinen, M L; Lidén, A; Alm, C; Nordin, C; Bertilsson, L.
Affiliation
  • Dahl-Puustinen ML; Department of Clinical Pharmacology, Karolinska Institute, Huddinge Hospital, Sweden.
Clin Pharmacol Ther ; 46(1): 78-81, 1989 Jul.
Article in En | MEDLINE | ID: mdl-2743709
ABSTRACT
The pharmacokinetics of a single oral dose of 6 mg perphenazine was studied in a group of six slow and six rapid hydroxylators of debrisoquin. Peak serum concentrations of perphenazine were significantly higher in slow hydroxylators than they were in rapid hydroxylators (2.4 +/- 0.6 versus 0.7 +/- 0.3 nmol/L, p less than 0.001). The AUC(0-12) was also higher in slow hydroxylators than it was in rapid hydroxylators (18.5 +/- 6.2 versus 4.5 +/- 2.5 nmol.L-1.hr, p less than 0.001). The data suggest that the disposition of the antipsychotic drug perphenazine covaries with polymorphic debrisoquin hydroxylation.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Perphenazine / Debrisoquin / Isoquinolines Limits: Adult / Female / Humans / Male Language: En Journal: Clin Pharmacol Ther Year: 1989 Document type: Article Affiliation country: Suecia
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Perphenazine / Debrisoquin / Isoquinolines Limits: Adult / Female / Humans / Male Language: En Journal: Clin Pharmacol Ther Year: 1989 Document type: Article Affiliation country: Suecia